Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
IgM antibody identifies good candidates for natalizumab
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Warner Chilcott sells Vectrin product line to Medicis
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
Is natalizumab overshooting its rebound?
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Neuromyelitis optica: clinical manifestations and neuroimaging features.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
155
156
157
158
159
160
161
162
163
…
next ›
last »